Do Weight-management Startups Have a Future?
A version of this story was published first on MedPage Today The effectiveness of GLP-1 agonists—e.g., semaglutide (Wegovy)—in reducing weight has caught nationwide attention, causing a frenzy among celebrities and the wealthy to get their hands on the drug. It has also prompted startups to launch new weight management programs. The weight-management space is the next “big” space. In my opinion,…
Read MoreFrom Fitness to Vital Signs: A Deep Dive into Wearable Tech
Wearable technology will soon become widespread and as regularly used as putting on shoes before leaving the house. Heck, I’m writing this newsletter with my Garmin watch on my left wrist and my WHOOP band on my right bicep. All I need is a wearable to measure my electrolytes. Then I’m set. I’m not the…
Read MoreLooking Back, Looking Ahead: Mark Cuban’s Cost Plus Drugs Company
A version of this story was published first on MedPage Today Just over a year since its launch, Mark Cuban’s Cost Plus Drug Company (Cost Plus Drugs) has appeared to reap nothing but success. I’m not at all surprised. As soon as I clicked “publish” on the first article I wrote about Cost Plus Drugs in January 2022, I knew…
Read MoreThe End of the Billion-Dollar Drug
AbbVie’s Humira, the most financially successful drug in history, will be saying goodbye to its 20-year throne of U.S. market exclusivity. That’s 20 years of zero competition in the U.S. Following years of lawsuits and AbbVie’s patent tactics, several Humira biosimilars will hit the market throughout the year, with the first one by Amgen hitting the market…
Read MoreHow Health Tech is Transforming the Hospital-at-Home Experience
The patient’s home is becoming a popular means of care delivery, no matter the acuity level. While some may think health at home is “novel,” it’s most certainly not. Forty percent of all U.S. doctor visits were performed in the patient’s home up until the 1980s. After the 1980s, however, house calls made up less than 1%…
Read MoreDigital Health Funding Slows in 2022: Is the Hype Fading or is it a Temporary Setback?
While 2022’s total digital health funding disappointed many, it was anything but unexpected. Throughout 2022, I frequently reported on digital health startups’ struggles, from fundraising to layoffs. While some digital health verticals had it tougher than others, it’s safe to say everyone suffered together. In this article, I’ll recap Rock Health’s annual digital health funding report, highlight funding trends…
Read More